BioProcess Insider - News BioProcess International

Pfizer unveils biosimilar launch plans and shares view on US market

Pfizer set out a busy programme of biosimilar launches in its Q3 call and shared its thoughts on the “rebate trough” and other challenges facing the US market. First the numbers. Pfizer finished the three months to the end of September with income of $7.7 billion (€7 billion) – up 87% ...

Horizon Discovery divests animal model biz to focus on cell lines
Envigo will acquire the rodent model business from Horizon Discovery for an undisclosed fee. The unit brought in £4.6 million ($5.9 million) of ...
AGC Bio to plough $18m in US and EU facilities
CDMO AGC Biologics will invest 2 billion Yen ($18.4 million) to increase biopharmaceutical production capacity at facilities in the US and Europe ...
Mesa Labs picks up Gyros in $180m bio QC deal
Swedish immunoassay and peptide synthesis firm Gyros Protein Technologies has been acquired by Mesa Laboratories in a deal worth $180 million (� ...
Aspen alert! Novartis buys assets for $330m in Japan boost
Novartis division Sandoz has acquired the Japanese business of Aspen Global Incorporated (AGI), bolstering its biosimilar and generics presence i ...

Covering the whole development process for the global biotechnology industry

More From BioProcess Insider

Recent Tweets

Recent Tweets

Trending